22/12/2008 (Agence Europe) - On Friday 19 December, the European Commission cleared the proposed acquisition of Barr Pharmaceuticals of the US by Teva Pharmaceutical Industries of Israel. This approval is, however, subject to Teva divesting 15 pharmaceuticals markets in the Czech Republic, Hungary, the Slovak Republic and Slovenia and 2 in Poland in an effort to satisfy Commission concerns over completion in the markets in question. (C.D./trans/rh)